Geron Corp (GERN):企業の財務・戦略的SWOT分析

◆英語タイトル:Geron Corp (GERN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH42160FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:62
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Geron Corp (GERN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Geron Corp (Geron) is a late-stage clinical biopharmaceutical company that focuses on the development and commercialization of imetelstat, a first-in-class telomerase inhibitor in hematologic myeloid malignancies. The company’s clinical studies include IMerge, a Phase 2 trial in lower risk myelodysplastic syndromes; and IMbark, a Phase 2 clinical trial in intermediate or high-risk myelofibrosis. Imetelstat received Fast Track designation from the US FDA to treat patients with transfusion-dependent anemia due to lower or intermediate risk myelodysplastic syndromes (MDS) and patients with intermediate or high-risk myelofibrosis (MF). The company utilizes core expertise in telomerase and telomere biology and its proprietary nucleic acid chemistry for the development of imetelstat. Geron is headquartered in Menlo Park, California, the US.

Geron Corp Key Recent Developments

Mar 11,2021: Geron Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Mar 01,2021: Geron to Announce Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021
Nov 05,2020: Geron reports third quarter 2020 financial results and current events
Oct 29,2020: Geron to Announce Third Quarter Financial Results on November 5, 2020
Aug 06,2020: Geron reports second quarter 2020 financial results and current events

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Geron Corp – Key Facts
Geron Corp – Key Employees
Geron Corp – Key Employee Biographies
Geron Corp – Major Products and Services
Geron Corp – History
Geron Corp – Company Statement
Geron Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Geron Corp – Business Description
R&D Overview
Geron Corp – SWOT Analysis
SWOT Analysis – Overview
Geron Corp – Strengths
Geron Corp – Weaknesses
Geron Corp – Opportunities
Geron Corp – Threats
Geron Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Geron Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Geron Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Geron Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 11, 2021: Geron Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Mar 01, 2021: Geron to Announce Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021
Nov 05, 2020: Geron reports third quarter 2020 financial results and current events
Oct 29, 2020: Geron to Announce Third Quarter Financial Results on November 5, 2020
Aug 06, 2020: Geron reports second quarter 2020 financial results and current events
May 28, 2020: Geron reports first quarter 2020 financial results
Mar 12, 2020: Geron reports fourth quarter and full year 2019 financial results and 2020 milestones
Feb 14, 2020: GERON: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
Jan 13, 2020: Geron announces 2019 accomplishments and key development priorities for 2020
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Geron Corp, Key Facts
Geron Corp, Key Employees
Geron Corp, Key Employee Biographies
Geron Corp, Major Products and Services
Geron Corp, History
Geron Corp, Other Locations
Geron Corp, Key Competitors
Geron Corp, Ratios based on current share price
Geron Corp, Annual Ratios
Geron Corp, Annual Ratios (Cont...1)
Geron Corp, Interim Ratios
Geron Corp, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Geron Corp, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Geron Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Geron Corp (GERN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sodexo SA:企業の戦略・SWOT・財務情報
    Sodexo SA - Strategy, SWOT and Corporate Finance Report Summary Sodexo SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Pharmaniaga Berhad (PHARMA):企業の財務・戦略的SWOT分析
    Pharmaniaga Berhad (PHARMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Airbus SE (AIR):企業の財務・戦略的SWOT分析
    Airbus SE (AIR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Canadian Spirit Resources Inc (SPI):石油・ガス:M&Aディール及び事業提携情報
    Summary Canadian Spirit Resources Inc (CSRI) is a natural resource provider that provides exploration and development services. The company offers exploration and production of natural gas in Montney Formation of Northeast British Columbia. It provides operation Farrell Creek area which is located a …
  • Wellington Management Company LLP:企業の戦略・SWOT・財務情報
    Wellington Management Company LLP - Strategy, SWOT and Corporate Finance Report Summary Wellington Management Company LLP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Urban One, Inc.:企業の戦略・SWOT・財務分析
    Urban One, Inc. - Strategy, SWOT and Corporate Finance Report Summary Urban One, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • RH Petrogas Ltd (T13):石油・ガス:M&Aディール及び事業提携情報
    Summary RH Petrogas Ltd (RH Petrogas) is an oil and gas company that explores, develops and produces oil and gas resources. The company’s properties include FUYU 1 block, Basin and Island PSC, and SK331 PSC. Its FUYU 1 block property is located in south-east of the Fuyu oilfield in the Jilin provinc …
  • Medical Facilities Corp (DR):企業の財務・戦略的SWOT分析
    Summary Medical Facilities Corp (MFC) is a healthcare service provider that provides inpatient and outpatient surgical procedures. It offers surgical equipment, non-surgical professional services, drugs and supplies, and other support services. Its specialty surgical division performs non-emergency …
  • Ashok Leyland Limited:企業の戦略・SWOT・財務情報
    Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report Summary Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • DiscGenics Inc-製薬・医療分野:企業M&A・提携分析
    Summary DiscGenics Inc (DiscGenics) is a biotechnology company that develops advanced spinal therapeutics. The company develops therapies to treat patients with intervertebral disc diseases. Its products comprise Injectable Discogenic Cell Therapy (IDCT), developed for treating patients with moderat …
  • UbiVac LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary UbiVac LLC (UbiVac) is a clinical stage immuno-oncology companythat offers immunotherapeutic products. The company offers research and development of therapeutic vaccines for the treatment of cancer and infectious diseases. Its pipeline product includes DPV-001, a DC-targeted complex vaccine …
  • CivaTech Oncology Inc:医療機器:M&Aディール及び事業提携情報
    Summary CivaTech Oncology Inc (CivaTech) is a medical device company that provides radiation therapy solutions. The company develops polymer based low dose rate (LDR) brachytherapy devices for the treatment of cancer. Its product portfolio includes CivaString, a radiation therapy device to treat sol …
  • Drax Group Plc (DRX)-エネルギー分野:企業M&A・提携分析
    Summary Drax Group plc (Drax) is a biomass-fuelled electricity generator, which generates electricity from coal and biomass. It operates across three principal areas of activity, electricity generation; electricity sales to business customers; and compressed wood pellet production. The company opera …
  • Dominion Energy Inc.:企業の戦略・SWOT・財務分析
    Dominion Energy Inc. - Strategy, SWOT and Corporate Finance Report Summary Dominion Energy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Illinois Municipal Electric Agency:企業の戦略的SWOT分析
    Illinois Municipal Electric Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Trinity Biotech Plc (TRIB):医療機器:M&Aディール及び事業提携情報
    Summary Trinity Biotech Plc (Trinity Biotech) is a medical equipment company which develops, acquires, manufactures and distributes diagnostic systems for clinical laboratory and point-of-care sectors. The company’s product portfolio encompasses diagnostic tests and instruments that are used to dete …
  • Idexx Laboratories Inc (IDXX)-製薬・医療分野:企業M&A・提携分析
    Summary Idexx Laboratories Inc (IDEXX) is a diagnostics company. It develops, manufactures and distributes products and services for small animals and livestock. The company offers veterinary reference laboratory diagnostics and consulting services, point-of-care veterinary diagnostic products, micr …
  • Beacon Roofing Supply Inc:企業のM&A・事業提携・投資動向
    Beacon Roofing Supply Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Beacon Roofing Supply Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Proteome Sciences Plc (PRM):製薬・医療:M&Aディール及び事業提携情報
    Summary Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services. Its proteomics services include drug development, biomarker discovery and provision of data insights. It maps the protein expression …
  • Enbridge Inc (ENB):企業の財務・戦略的SWOT分析
    Enbridge Inc (ENB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆